# Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation

> **NCT02584283** · PHASE3 · COMPLETED · sponsor: **Robert J. Porte** · enrollment: 157 (actual)

## Conditions studied

- Liver Failure
- End Stage Liver Disease
- Biliary Tract Diseases

## Interventions

- **PROCEDURE:** Dual hypothermic oxygenated perfusion
- **DEVICE:** Liver Assist®
- **PROCEDURE:** Perfusion fluid
- **DRUG:** Glutathione

## Key facts

- **NCT ID:** NCT02584283
- **Lead sponsor:** Robert J. Porte
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584283, "Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02584283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*